Authors


Robert L. Hendren, DO

Latest:

Update on Autism

Autism is demanding increased attention by professional and lay audiences; prevalence seems to be increasing. There are differing opinions about whether the increase is due to greater recognition and reporting, diagnostic expansion and substitution, or increasing acceptability.


Robert L. Pyles, MD

Latest:

We Shall Fight Them on the Beaches

Settlements by two insurance companies in the RICO lawsuit could have an major impact on psychiatry practices.


Robert L. Spitzer, MD

Latest:

Response to: “Psychiatric Symptoms Can be Understood Even When These Symptoms Cannot Be Explained”

Dr Muller, in his piece “Psychiatric Symptoms Can be Understood Even When These Symptoms Cannot Be Explained,” makes a number of assertions about DSM-III and its successors that reflect a mischaracterization of its “descriptive approach.”


Robert L. Trestman, PhD, MD

Latest:

Clinical Implications of Working With Patients on Parole or Probation

Many patients with serious mental illness become entangled with the justice system. Extending our notions of interdisciplinary teams to include parole and probation officers provides us with options and opportunities not typically available otherwise in support of our patients.



Robert Levine, MD

Latest:

Why Evidence-Based Medicine Cannot Be Applied to Psychiatry

Evidence-based medicine (EBM) is rapidly becoming the norm. It is taught in medical schools and is encouraged by both government agencies and insurance plan providers. Yet, there is little proof that this model can be adapted to fit psychiatry.


Robert M. Anthenelli, MD

Latest:

Smoking Cessation During Substance Abuse Treatment

An overview of the critical issues involved in overcoming personal and organizational barriers to help substance abusers quit smoking.


Robert M. Bilder, PhD

Latest:

From Bench to Bedside: The Future of Neuroimaging Tools in Diagnosis and Treatment

Schizophrenia poses a challenge for diagnosis and treatment at least in part because it remains a syndromal diagnosis without clearly understood neuropathological bases or treatments with clearly understood mechanisms of action. Neuroimaging research promises to advance understanding of the unique pathological processes that contribute to this syndrome, and to foster both better appreciation of how current treatments work, and how future treatments should be developed.


Robert M. Bossarte, PhD

Latest:

Improving Understanding of Veteran Suicide Relative to VHA Service Use

The authors summarize findings from the first study to compare suicide risk for veterans who do and those who do not use VA services.


Robert M. Mccarron, DO

Latest:

Somatization in the Primary Care Setting

Somatoform disorders (disorders that are not fully explained by a medical condition or mental disorder) may require psychiatrists to consult with physicians.


Robert M. Post, MD

Latest:

At-Risk Children in the US Deserve Careful Assessment

In an international network of patients with bipolar illness, more offspring of US patients than of those from Europe had received a mental illness diagnosis. This suggests greater epigenetic vulnerability in Americans.


Robert Mckelvey, MD

Latest:

Vietnamese Amerasians and Former Political Prisoners

Vietnamese Amerasians and the former political prisoners of South Vietnam are living legacies of the Vietnam War. Now that many live in the United States, it is important for psychiatrists to have an understanding of their life experiences and be able to recognize psychiatric disorders that are common among them.


Robert Mendola, MD

Latest:

Working Within a Campus Health Service: A Challenge With Many Rewards

Psychiatrists can provide significant support and insight to patients who are now coming to campus with a wide array of mental health challenges.


Robert Michels, MD

Latest:

Research-Based Psychotherapy

The practice of one human being helping another to feel better through the use of talk is as old as humanity itself. As a profession, however, psychiatry has existed for only 100 years.


Robert N. Golden, MD

Latest:

Special Populations, Emerging Treatments and Persistent Challenges

Over the past quarter-century, new treatments for depression have emerged that are as effective as original pharmacotherapies but have fewer side effects. Yet, full remission and access to care remain out of reach for so many people. In this introduction to our Depressive Disorders Special Report, Dr. Golden encourages readers to see the glass as half-full.


Robert Nastasi, MD

Latest:

Seroconversion: From Unconscious to Conscious and Back

The journey of switching specialties from anesthesia to psychiatry, from OR to office.


Robert P. Granacher Jr, MD, MBA

Latest:

Traumatic Brain Injury and Posttraumatic Stress Disorder

Our returning military veterans remind us dramatically of the importance to consider traumatic brain injury (TBI) as a potential comorbid illness in cases of posttraumatic stress disorder (PTSD). The common causes of comorbid TBI and PTSD are assault and battery to the head, head trauma (personal or work-related injuries), civilian or military explosions, inflicted head trauma in children, motor vehicle accidents, and suicide attempts by jumping. Prevalence figures for comorbid TBI and PTSD historically have been lacking


Robert R. (roy) Hazelwood, MS

Latest:

Pioneering FBI Profiler Answers Questions About Serial Killers

Here, Mr Hazelwood answers questions about serial murderers that are commonly posed to him. The term serial murderer (or serial killer) was not even a part of the forensic lexicon until the 1970s . . .


Robert S. Biskin, MDCM

Latest:

Comorbidities in Borderline Personality Disorder

Borderline personality disorder typically coexists with depression, anxiety, and substance abuse. Symptoms of these conditions may lead the clinician to miss the diagnosis of personality disorder entirely. Careful diagnosis of BPD and comorbid disorders is the first step.


Robert Short, MA

Latest:

Adaptation and Implementation of the Integrated Dual Diagnosis Treatment Model Into a Psychiatric Inpatient Facility: A 12-Year Perspective

As early as the 1970s, researchers and practitioners became increasingly aware of the necessity for services that would address the varied needs and treatment implications for consumers with the co-occurring disorders of substance abuse and mental illness. High percentages of consumers in substance abuse treatment centers were identified with mental illness disorders, and consumers admitted to psychiatric facilities often were identified as having additional substance use disorders.


Robert Spitzer, MD

Latest:

A Letter to the Board of Trustees of the APA

We are delighted that you have appointed a DSM-5 Scientific Review Work Group and charged it with assessing the quality of evidence supporting the DSM 5 proposals.This is great news, probably the last hope to weed out proposals that could do great harm to the Association, our field, and to our patients.


Robert T. Carter, PhD

Latest:

Race-Based Traumatic Stress

In 2001, the US Surgeon General issued a report about the status of mental health with respect to racial and ethnic minority groups, which stated that ethnic and racial disparities were likely due to racism and discrimination. Empiric investigations have linked racism to poor mental health and have shown that racism is stressful and compromises the mental health of persons of color.


Robert Taylor Segraves, MD, PhD

Latest:

Clinical Manual of Sexual Disorders

This 3-part manual on sexual disorders is edited by 2 psychiatrists who have been engaged for more than 20 years in clinical treatment of patients with sexual problems.


Robert W. Mccarley, MD

Latest:

Neuropsychiatric Abnormalities: A New Vista From Studies on Fundamental Properties of Neural Communication

Postmortem studies indicate that neural circuit abnormalities in schizophrenia could be reflected in gamma-band synchrony. We review findings of recent studies that demonstrate abnormal synchrony in the gamma band of the EEG in chronic schizophrenia patients, and point to links between gamma oscillations and some of the core symptoms of schizophrenia.


Roberto Lewis-Fernández, MD

Latest:

Helping Primary Care Teams Provide Culturally Appropriate Care for Diverse Patients

Psychiatrists may wish to engage the primary care team to conduct a comprehensive case formulation that takes cultural factors into account.


Roberto Lewis-Fernández, MD, MTS

Latest:

The DSM-5 Cultural Formulation Interview and the Evolution of Cultural Assessment in Psychiatry

This evidence-based tool is composed of a series of questionnaires that assist clinicians in making person-centered cultural assessments to inform diagnosis and treatment planning.


Robin A. Hurley, MD, FANPA

Latest:

A Practical Update on Neuroimaging for Psychiatric Disorders

Which neuroimaging test for which psychiatric patient-and when? What to ask the neuroradiologist?


Robin Crew

Latest:

One More Thing to Worry About

A new study recently posted online by researchers at Kaiser Permanente in Oakland, Calif, offers prospective parents one more reason to worry. The study showed that pregnant women who have symptoms of depression are at increased risk for giving birth prematurely.1


Robin J. Casten, PhD

Latest:

Vision Loss and Depression in the Elderly

The emotional and functional consequences of sensory impairment in older persons have not been well studied despite the increasing prevalence of vision loss, in particular, and its substantial adverse effects. This review examines the impact of vision loss on psychological health, discusses factors that may reduce its negative effects, and describes new in terventions to help older people cope with eye diseases such as age-related macular degeneration (AMD).


Robin M. Kowalski, PhD

Latest:

Cyber Bullying

When most people think of bullying, they envision the schoolyard thug verbally or physically threatening hapless victims on the playground or on the school bus. The past few years, however, have witnessed a new type of bullying-cyber bullying-also known as electronic bullying or online social cruelty.

© 2024 MJH Life Sciences

All rights reserved.